NYSE · Drug Manufacturers - Specialty & Generic

Dr. Reddy's Laboratories Ltd (RDY) Stock

$12.48 +2.30% NYSE: RDY Healthcare

Valuation

MetricValue
Price$12.48
Market Cap$10.40B
P/E Ratio30.37
P/B Ratio2.62
P/S Ratio3.03
EPS (TTM)$53.92
52-Week High$15.67
52-Week Low$11.36
Dividend Yield0.65%

Financials & Margins

MetricValue
ROE8.88%
ROA5.75%
ROCE8.43%
Gross Margin13.83%
Operating Margin13.83%
Net Margin10.00%
Debt/Equity0.19
Current Ratio1.80

Annual Financials (USD)

Metric20222023202420252026
Revenue$214.4B$245.9B$279.2B$325.5B$353.5B
Operating Profit$29.5B$57.1B$67.7B$71.8B$48.9B
Net Profit$23.6B$45.1B$55.7B$56.5B$45.1B
EPS$28.34$54.17$66.80$67.77$53.92
Op Margin13.8%23.2%24.3%22.1%13.8%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$292.8B$321.9B$387.5B$493.0B$567.9B
Total Liabilities$102.3B$90.9B$107.0B$155.8B$195.0B
Cash$14.9B$5.8B$7.1B$14.7B$15.1B
Borrowings$33.8B$13.5B$20.0B$46.8B$75.8B

Latest News

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading MT Newswires · Jul 10, 2026 Asian Equities Traded in the US as American Depositary Receipts Advance in Thursday Trading MT Newswires · Jul 9, 2026 Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading MT Newswires · Jul 7, 2026 Asian Equities Traded in the US as American Depositary Receipts Soar in Monday Trading MT Newswires · Jul 6, 2026 Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading MT Newswires · Jul 1, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$28.1B$58.9B$45.4B$46.4B$56.6B
Investing Cash Flow$-45.4B$-60.2B$-67.7B$-92.5B$-95.1B
Financing Cash Flow$-1.3B$-1.9B$-2.3B$2.2B$-1.3B
Net Cash Flow$32.0M$-9.1B$1.3B$7.5B$-876.0M
Free Cash Flow$9.1B$40.0B$18.0B$12.0B$32.1B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.73
EV / EBITDA15.98
FCF Yield1.46%
Quick Ratio1.39
Interest Coverage8.47
Return 1Y-10.73%
Return 3Y-4.02%
Return 5Y0.09%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Dr. Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd is led by CEO Erez Israeli, employs 27,527 people, headquartered in Hyderabad, IN, publicly traded since 2001.

Dr. Reddy's Laboratories Ltd (RDY) stock trades at $12.48 with a market capitalization of $10.40B. The stock is valued at a price-to-earnings (P/E) ratio of 30.37, price-to-book of 2.62, price-to-sales of 3.03. Over the past 52 weeks the stock has ranged between $11.36 and $15.67, and currently trades 20.4% below its 52-week high. It pays a dividend yielding 0.65%.

On profitability, Dr. Reddy's Laboratories Ltd generates a return on equity (ROE) of 8.88%, return on capital employed of 8.43%, an operating margin of 13.83%, a net profit margin of 10.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides